Regeneron Pharmaceuticals Inc. buy BMO Capital Markets
Start price
30.04.25
/
50%
€515.60
Target price
30.04.26
€703.60
Performance (%)
15.46%
End price
01.05.26
€595.30
Summary
This prediction ended on 01.05.26 with a price of €595.30. The BUY prediction by BMO_Capital_Markets finished with a performance of 15.46%. BMO_Capital_Markets has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Dividends of €3.58 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 2.644% | 2.644% | 22.964% |
| iShares Core DAX® | 0,56 % | 0,44 % | 5,87 % |
| iShares Nasdaq 100 | -0,16 % | 1,62 % | 37,06 % |
| iShares Nikkei 225® | 1,10 % | 9,61 % | 65,64 % |
| iShares S&P 500 | 0,01 % | 0,69 % | 25,68 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target lowered by analysts at BMO Capital Markets from $865.00 to $800.00. They now have an "outperform" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€494.10
04.08.25
04.08.25
€552.90
04.08.26
04.08.26
10.37%
11:29
11:29
Stopped prediction by BMO_Capital_Markets for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€541.10
18.05.26
18.05.26
€628.24
18.05.27
18.05.27
0.28%
11:29
11:29
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€625.20
04.12.25
04.12.25
€728.79
04.12.26
04.12.26
-13.06%
11:29
11:29
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€427.60
02.06.25
02.06.25
€527.70
02.06.26
02.06.26
20.00%
03.06.26
03.06.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€681.40
04.02.25
04.02.25
€869.77
04.02.26
04.02.26
-4.08%
05.02.26
05.02.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€779.00
01.11.24
01.11.24
€1,096.8
01.11.25
01.11.25
-27.09%
02.11.25
02.11.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€939.20
24.09.24
24.09.24
€1,165.3
24.09.25
24.09.25
-47.87%
25.09.25
25.09.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€858.00
05.02.24
05.02.24
€1,006.8
05.02.25
05.02.25
-19.14%
06.02.25
06.02.25